Amgen, Takeda, UCB enrol first patient in Covid-19 global platform study

This article was originally published here

Three drugmakers are part of the COVID R&D Alliance, which was established in March this year to boost the study candidates without regard to company affiliation. The alliance,

The post Amgen, Takeda, UCB enrol first patient in Covid-19 global platform study appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply